Stay updated on Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial
Sign up to get notified when there's something new on the Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial page.

Latest updates to the Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an opportunity for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.9%
- Check10 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check46 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed information about a clinical study on Mepolizumab for severe eosinophilic asthma, while adding new collaborators and a revision update.SummaryDifference41%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check61 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
Stay in the know with updates to Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial page.